4.5 Article

Naphthoquinone-induced arylation inhibits Sirtuin 7 activity

期刊

JOURNAL OF CELL SCIENCE
卷 135, 期 8, 页码 -

出版社

COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.259207

关键词

rDNA transcription; pre-rRNA processing; 53BP1; Menadione; Plumbagin; SIRT7

资金

  1. Centre National de la Recherche Scientifique
  2. Universite Paris Cite
  3. Canceropole Ile-de-France
  4. Agence Nationale de la Recherche (AlveolusMimics) [ANR-17-CE09-0017]

向作者/读者索取更多资源

Natural or synthetic naphthoquinones interfere with biological systems and exhibit anticancer properties. They generate reactive oxygen species and react with nucleophiles, inhibiting the activity of the enzyme Sirtuin 7. This inhibition of Sirtuin 7 may be crucial in defining naphthoquinones as anti-tumor agents.
Natural or synthetic naphthoquinones have been identified to interfere with biological systems and, in particular, exhibit anticancer properties. As redox cyclers, they generate reactive oxygen species in cells and, as electrophiles, they react with nucleophiles, mainly thiols, and form covalent adducts. To further decipher the molecular mechanism of action of naphthoquinones in human cells, we analyzed their effects in HeLa cells. First, we demonstrated that the naphthoquinones menadione and plumbagin inhibited the nucleolar NAD(+)-dependent deacetylase Sirtuin 7 in vitro. As assessed by their inhibition of rDNA transcription, pre-rRNA processing and formation of etoposide-induced 53BP1 foci, menadione and plumbagin also inhibited Sirtuin 7 catalytic activity in vivo. Second, we established that when sulfhydryl arylation by menadione or plumbagin was prevented by the thiol reducing agent N-acetyl-L-cysteine, the inhibition of Sirtuin 7 catalytic activity was also blocked. Finally, we discuss how inhibition of Sirtuin 7 might be crucial in defining menadione or plumbagin as anti-tumor agents that can be used in combination with other anti-tumor strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据